Literature DB >> 19956259

Regulation of adaptive behaviour during fasting by hypothalamic Foxa2.

Jose P Silva1, Ferdinand von Meyenn, Jessica Howell, Bernard Thorens, Christian Wolfrum, Markus Stoffel.   

Abstract

The lateral hypothalamic area is considered the classic 'feeding centre', regulating food intake, arousal and motivated behaviour through the actions of orexin and melanin-concentrating hormone (MCH). These neuropeptides are inhibited in response to feeding-related signals and are released during fasting. However, the molecular mechanisms that regulate and integrate these signals remain poorly understood. Here we show that the forkhead box transcription factor Foxa2, a downstream target of insulin signalling, regulates the expression of orexin and MCH. During fasting, Foxa2 binds to MCH and orexin promoters and stimulates their expression. In fed and in hyperinsulinemic obese mice, insulin signalling leads to nuclear exclusion of Foxa2 and reduced expression of MCH and orexin. Constitutive activation of Foxa2 in the brain (Nes-Cre/+;Foxa2T156A(flox/flox) genotype) results in increased neuronal MCH and orexin expression and increased food consumption, metabolism and insulin sensitivity. Spontaneous physical activity of these animals in the fed state is significantly increased and is similar to that in fasted mice. Conditional activation of Foxa2 through the T156A mutation expression in the brain of obese mice also resulted in improved glucose homeostasis, decreased fat and increased lean body mass. Our results demonstrate that Foxa2 can act as a metabolic sensor in neurons of the lateral hypothalamic area to integrate metabolic signals, adaptive behaviour and physiological responses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19956259     DOI: 10.1038/nature08589

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  21 in total

1.  Melanin-concentrating hormone overexpression in transgenic mice leads to obesity and insulin resistance.

Authors:  D S Ludwig; N A Tritos; J W Mastaitis; R Kulkarni; E Kokkotou; J Elmquist; B Lowell; J S Flier; E Maratos-Flier
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

2.  Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity.

Authors:  J Hara; C T Beuckmann; T Nambu; J T Willie; R M Chemelli; C M Sinton; F Sugiyama; K Yagami; K Goto; M Yanagisawa; T Sakurai
Journal:  Neuron       Date:  2001-05       Impact factor: 17.173

3.  Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior.

Authors:  T Sakurai; A Amemiya; M Ishii; I Matsuzaki; R M Chemelli; H Tanaka; S C Williams; J A Richardson; G P Kozlowski; S Wilson; J R Arch; R E Buckingham; A C Haynes; S A Carr; R S Annan; D E McNulty; W S Liu; J A Terrett; N A Elshourbagy; D J Bergsma; M Yanagisawa
Journal:  Cell       Date:  1998-02-20       Impact factor: 41.582

4.  Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety.

Authors:  F Tronche; C Kellendonk; O Kretz; P Gass; K Anlag; P C Orban; R Bock; R Klein; G Schütz
Journal:  Nat Genet       Date:  1999-09       Impact factor: 38.330

5.  Orexin A activates locus coeruleus cell firing and increases arousal in the rat.

Authors:  J J Hagan; R A Leslie; S Patel; M L Evans; T A Wattam; S Holmes; C D Benham; S G Taylor; C Routledge; P Hemmati; R P Munton; T E Ashmeade; A S Shah; J P Hatcher; P D Hatcher; D N Jones; M I Smith; D C Piper; A J Hunter; R A Porter; N Upton
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

Review 6.  To eat or to sleep? Orexin in the regulation of feeding and wakefulness.

Authors:  J T Willie; R M Chemelli; C M Sinton; M Yanagisawa
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

7.  The association of intensity and overall level of physical activity energy expenditure with a marker of insulin resistance.

Authors:  F K Assah; S Brage; U Ekelund; N J Wareham
Journal:  Diabetologia       Date:  2008-05-17       Impact factor: 10.122

8.  Derivation of completely cell culture-derived mice from early-passage embryonic stem cells.

Authors:  A Nagy; J Rossant; R Nagy; W Abramow-Newerly; J C Roder
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

9.  Crucial role of a long-chain fatty acid elongase, Elovl6, in obesity-induced insulin resistance.

Authors:  Takashi Matsuzaka; Hitoshi Shimano; Naoya Yahagi; Toyonori Kato; Ayaka Atsumi; Takashi Yamamoto; Noriyuki Inoue; Mayumi Ishikawa; Sumiyo Okada; Naomi Ishigaki; Hitoshi Iwasaki; Yuko Iwasaki; Tadayoshi Karasawa; Shin Kumadaki; Toshiyuki Matsui; Motohiro Sekiya; Ken Ohashi; Alyssa H Hasty; Yoshimi Nakagawa; Akimitsu Takahashi; Hiroaki Suzuki; Sigeru Yatoh; Hirohito Sone; Hideo Toyoshima; Jun-ichi Osuga; Nobuhiro Yamada
Journal:  Nat Med       Date:  2007-09-30       Impact factor: 53.440

10.  Associations between overall physical activity level and cardiovascular risk factors in an adult population.

Authors:  Mette Aadahl; Michael Kjaer; Torben Jørgensen
Journal:  Eur J Epidemiol       Date:  2007-02-28       Impact factor: 12.434

View more
  38 in total

1.  Genome-wide characterization of Foxa2 targets reveals upregulation of floor plate genes and repression of ventrolateral genes in midbrain dopaminergic progenitors.

Authors:  Emmanouil Metzakopian; Wei Lin; Mali Salmon-Divon; Heidi Dvinge; Elisabet Andersson; Johan Ericson; Thomas Perlmann; Jeffrey A Whitsett; Paul Bertone; Siew-Lan Ang
Journal:  Development       Date:  2012-06-13       Impact factor: 6.868

2.  Molecular profiling of neurons based on connectivity.

Authors:  Mats I Ekstrand; Alexander R Nectow; Zachary A Knight; Kaamashri N Latcha; Lisa E Pomeranz; Jeffrey M Friedman
Journal:  Cell       Date:  2014-05-22       Impact factor: 41.582

3.  Translational profiling of hypocretin neurons identifies candidate molecules for sleep regulation.

Authors:  Jasbir Dalal; Jee Hoon Roh; Susan E Maloney; Afua Akuffo; Samir Shah; Han Yuan; Brie Wamsley; Wendell B Jones; Cristina de Guzman Strong; Paul A Gray; David M Holtzman; Nathaniel Heintz; Joseph D Dougherty
Journal:  Genes Dev       Date:  2013-02-21       Impact factor: 11.361

Review 4.  Metabolic and hedonic drives in the neural control of appetite: who is the boss?

Authors:  Hans-Rudolf Berthoud
Journal:  Curr Opin Neurobiol       Date:  2011-10-06       Impact factor: 6.627

5.  Transcriptional regulation of the hypocretin/orexin gene by NR6A1.

Authors:  Susumu Tanaka; Tohru Kodama; Takashi Nonaka; Hiromi Toyoda; Makoto Arai; Miyuki Fukazawa; Yoshiko Honda; Makoto Honda; Emmanuel Mignot
Journal:  Biochem Biophys Res Commun       Date:  2010-11-05       Impact factor: 3.575

Review 6.  Prolonged fasting as a method of mood enhancement in chronic pain syndromes: a review of clinical evidence and mechanisms.

Authors:  Andreas Michalsen
Journal:  Curr Pain Headache Rep       Date:  2010-04

7.  DEC2 modulates orexin expression and regulates sleep.

Authors:  Arisa Hirano; Pei-Ken Hsu; Luoying Zhang; Lijuan Xing; Thomas McMahon; Maya Yamazaki; Louis J Ptáček; Ying-Hui Fu
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-12       Impact factor: 11.205

8.  Vagal Blocking for Obesity Control: a Possible Mechanism-Of-Action.

Authors:  Helene Johannessen; David Revesz; Yosuke Kodama; Nikki Cassie; Karolina P Skibicka; Perry Barrett; Suzanne Dickson; Jens Holst; Jens Rehfeld; Geoffrey van der Plasse; Roger Adan; Bård Kulseng; Elinor Ben-Menachem; Chun-Mei Zhao; Duan Chen
Journal:  Obes Surg       Date:  2017-01       Impact factor: 4.129

9.  Nato3 integrates with the Shh-Foxa2 transcriptional network regulating the differentiation of midbrain dopaminergic neurons.

Authors:  Einat Nissim-Eliraz; Sophie Zisman; Omri Schatz; Nissim Ben-Arie
Journal:  J Mol Neurosci       Date:  2012-12-21       Impact factor: 3.444

Review 10.  Fox transcription factors: from development to disease.

Authors:  Maria L Golson; Klaus H Kaestner
Journal:  Development       Date:  2016-12-15       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.